Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/ANNEXIN-PHARMACEUTICALS-A-39436694/news/Annexin-Pharmaceuticals-AB-Announces-First-Patient-Dosed-in-Annexin-s-Phase-2-Study-in-Retinal-Vein-42252606/?utm_source=whatsapp&utm_medium=social&utm_campaign=share